Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mooney, C.
Right arrow Articles by Phelps, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mooney, C.
Right arrow Articles by Phelps, C. E.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*MRI Scans
*Multiple Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Targeting Assessments of Magnetic Resonance Imaging in suspected Multiple sclerosis

Cathleen Mooney, RN, MS

Alvin I. Mushlin, MD, ScM

Charles E. Phelps, PhD

Decision-analytic methods can be valuable for targeting research in technology assessment. They can indicate whether further evaluation of a technology is warranted, and if so, which variables are key determinants of its clinical utility and cost-effectiveness. This approach was tested on a salient issue—whether magnetic resonance imaging (MR) should be used in evaluating patients with mild neurologic symptoms who might have multiple sclerosis (MS). The authors developed a decision-analytic model to assess the expected utility and costs associated with immediately using MR in this situation, compared with waiting for further symptoms to emerge before testing. Sensitivity analyses demonstrated that priorities for technology assessment research include estimating the value of information to patients in resolving uncertainty, evaluating the impact on patients of being labeled with a diagnosis of MS, and measuring the test characteristics of MR. Key words: cost-benefit analysis; multiple sclerosis; magnetic resonance imaging; decision analysis; Markov models. (Med Decis Making 1990;10:77-94)

Medical Decision Making, Vol. 10, No. 2, 77-94 (1990)
DOI: 10.1177/0272989X9001000201


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
F. Yokota and K. M. Thompson
Value of Information Literature Analysis: A Review of Applications in Health Risk Management
Med Decis Making, June 1, 2004; 24(3): 287 - 298.
[Abstract] [PDF]


Home page
InterfacesHome page
G. B. Hazen, J. M. Pellissier, and J. Sounderpandian
Stochastic-Tree Models in Medical Decision Making
Interfaces, July 1, 1998; 28(4): 64 - 80.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
G. B. Hazen
Stochastic Trees: A New Technique for Temporal Medical Decision Modeling
Med Decis Making, August 1, 1992; 12(3): 163 - 178.
[Abstract] [PDF]